Search Results 301-310 of 17260 for egfr

1. Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024) - Mayo Clinic

   EGFR sensitizing mutation and/or ALK translocation; Currently participating or has participated in a study of an investigational agent or using an ...

2. TRITON-CM: A Study To Evaluate Nucresiran In Patients With Transthyretin Amyloidosis With Cardiomyopathy - Mayo Clinic

   * Has an estimated glomerular filtration rate eGFR of \<30 mL/min/1.73m\^2 at screening. * Has received prior or currently receiving TTR-lowering therapy.

3. Efficacy And Safety Of Encaleret Compared To Standard Of Care In Participants With ADH1 - Mayo Clinic

   Estimated glomerular filtration rate (eGFR) <30 mL/minute/1.73 m^2 using chronic kidney disease-EPI creatinine equation refit without the race variable ...

4. I-124 evuzamitide PET/CT Imaging for the Diagnosis of Cardiac Amyloidosis - Mayo Clinic

   eGFR less than 15ml/min/1.73m2. Myocardial infarction within three (3) months of screening. Has severe claustrophobia or any medical condition that would ...

5. NEXUS Study: A Study To Test Single And Multiple Doses Of MER511 Given To Adults With Graves' Disease - Mayo Clinic

   Estimated glomerular filtration rate (eGFR) \<85 mL/min/1.73 m2 using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) creatinine equation 17 ...

6. A Study Using Magnetic Resonance Imaging (MRI) as a Non-invasive Method for Assessing Pancreatic Fibrosis (MINIMAP) - Mayo Clinic

   Known estimated glomerular filtration rate (eGFR) < 45 ml/min/1.73m2. Severe COPD limiting breath-holding for MRI. Moderate or large volume ascites (of any ...

7. CLIP-IT Post Market Study: Exclusion of the Left Atrial Appendage With Penditure™ - Mayo Clinic

   * Chronic Kidney Disease Stage IV or V (eGFR \<30 ml/min) * NYHA Class IV heart failure symptoms * Patient has a documented history of substance (drug or ...

8. Pilot Study of Rituximab to Treat Fibrillary Glomerulonephritis - Mayo Clinic

   eGFR greater than or equal to 25 mL/ min using CKD EPI formula or a quantified creatinine clearance > 25mL/ min and/or serum creatinine <3.0 mg/dL; Negative ...

9. A Phase 1 Trial of MK-4280 as Monotherapy and in Combination with Pembrolizumab with or without Chemotherapy or Lenvatinib (E7080/MK 7902) in Subjects with Advanced Solid Tumors - Mayo Clinic

   Subjects eligible to receive EGFR-targeted therapy must have previously received this treatment in order to be eligible for the study. Note – Subjects with ...

10. End-stage kidney disease - Care at Mayo Clinic

    When kidney disease becomes very advanced and kidneys no longer work well enough to meet your body's needs, treatment involves kidney dialysis or kidney ...